To include your compound in the COVID-19 Resource Center, submit it here.

CPI-300 regulatory update

Earlier this year, the U.S. District Court for the District of Delaware dismissed a lawsuit against IntelGenx filed by Biovail Corp.

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE